Jazz Pharmaceuticals plc JAZZ

NAS: JAZZ | ISIN: IE00B4Q5ZN47   12/12/2025
167,50 USD (+1,58%)
(+1,58%)   12/12/2025
Grafiek Jazz Pharmaceuticals plc Grafiek Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc in het nieuws

5 december 2025 · Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting · Persbericht

2 december 2025 · Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium · Persbericht

18 november 2025 · Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference · Persbericht

17 november 2025 · Positive HERIZON-GEA-01 Phase 3 Results Support Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and Ziihera Combination Regimens as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma · Persbericht

11 november 2025 · Jazz Pharmaceuticals Showcases New Clinical and Translational Data for Modeyso™ (dordaviprone) in H3 K27M-mutant Diffuse Midline Glioma at SNO 2025 · Persbericht

5 november 2025 · Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance · Persbericht

28 oktober 2025 · Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors · Persbericht

22 oktober 2025 · Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025 · Persbericht

3 oktober 2025 · FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer · Persbericht

22 september 2025 · Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses · Persbericht

Profiel Jazz Pharmaceuticals plc

Fabricage van farmaceutische preparaten
Farmaceutische producten: Andere
Gezondheidstechnologie
Productie

Mijn selecties